PuSH - Publication Server of Helmholtz Zentrum München

Rauer, L. ; Reiger, M. ; Bhattacharyya, M.* ; Brunner, P.M.* ; Krueger, J.G.* ; Guttman-Yassky, E.* ; Traidl-Hoffmann, C. ; Neumann, A.U.

Skin microbiome and its association with host cofactors in determining atopic dermatitis severity.

J. Eur. Acad. Dermatol. Venereol. 37, 772-782 (2022)
Publ. Version/Full Text Postprint Research data DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
BACKGROUND: Atopic dermatitis (AD) is a heterogeneous, chronic inflammatory skin disease linked to skin microbiome dysbiosis with reduced bacterial diversity and elevated relative abundance of Staphylococcus aureus (S. aureus). OBJECTIVES: We aimed to characterize the yet-incompletely understood association between the skin microbiome and patients' demographic and clinical cofactors in relation to AD severity. METHODS: The skin microbiome in 48 adult moderate-to-severe AD patients was investigated using next-generation deep sequencing (16S rRNA gene, V1-V3 region) followed by denoising (DADA2) to obtain amplicon sequence variant (ASV) composition. RESULTS: In lesional skin, AD severity was associated with S. aureus relative abundance (rS =0.53, p<0.001) and slightly better with the microbiome diversity measure Evenness (rS =-0.58, p<0.001), but not with Richness. Multiple regression confirmed the association of AD severity with microbiome diversity, including Shannon (in lesional skin, p<0.001), Evenness (in non-lesional skin, p=0.015), or S. aureus relative abundance (p<0.012), and with patient's IgE levels (p<0.001), race (p<0.032), age (p<0.034) and sex (p=0.012). The lesional model explained 62% of the variation in AD severity, and the non-lesional model 50% of the variation. CONCLUSIONS: Our results specify the frequently reported "reduced diversity" of the AD-related skin microbiome to reduced Evenness, which was in turn mainly driven by S. aureus relative abundance, rather than to a reduced microbiome Richness. Finding associations between AD severity, the skin microbiome and patient's cofactors is a key aspect in developing new personalized AD treatments, particularly those targeting the AD microbiome.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
9.228
0.000
5
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Staphylococcus-aureus; Scorad Index; Disease; Eczema; Children; Ige
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 0926-9959
e-ISSN 1468-3083
Quellenangaben Volume: 37, Issue: 4, Pages: 772-782 Article Number: , Supplement: ,
Publisher Wiley
Publishing Place 111 River St, Hoboken 07030-5774, Nj Usa
Reviewing status Peer reviewed
Institute(s) Institute of Environmental Medicine (IEM)
POF-Topic(s) 30202 - Environmental Health
Research field(s) Allergy
PSP Element(s) G-503400-001
Grants Helmholtz Association, Germany
Helmholtz Center Munich
Scopus ID 85147109119
PubMed ID 36433676
Erfassungsdatum 2022-12-09